Technology

Meta Platforms, Inc. (Nasdaq:META) has released its financial results for the quarter and full year ended December 31, 2025.CEO Mark Zuckerberg stated, "We had strong business performance in 2025. I'm looking forward to advancing personal superintelligence for people around the world in 2026."The report …

Despite 2025's challenges, Australia's technology sector houses world-class companies with global reach, recurring revenue models, and strong competitive positions. These businesses didn't lose their economic moats overnight. Rather, a combination of rising interest rates, concerns about an AI bubble, and company-specific issues forced the …

DroneShield Limited (ASX:DRO), a counter-drone technology provider, released its 4Q25 and FY2025 investor presentation outlining accelerated revenue, cash receipts, and SaaS growth.Revenuefrom customers totalled AUD 216.5m in FY2025 compared with AUD 57.5m in FY2024. Customer cash receipts increased to AUD 201.6m, up from AUD …

Elsight Ltd (ASX:ELS) continued its positive momentum on 27 January 2026, rising2.78%in today’s trading session, building on a35% year-to-date increase. The share price surge follows the company’s record Q4 2025 results, which included historicquarterlyrevenue, expanding global contracts, and the delivery of its first Aura …

Anteris Technologies Global Corp (ASX:AVR) (NASDAQ:AVR) share price surged by 9.43% to AUD 9.75 on 23 January 2026, following the announcement of USD 320 million in gross proceeds raised through an underwritten public offering and a strategicprivate placementwith Medtronic. The capital will support the …

Life360 (ASX:360) shares closed at 33.84 AUD on 23 January, rising 27.57% or 7.32 AUD in a single session. The surge follows the release of preliminary Q4 2025 and full-year operational performance data, indicating notable user and subscriber growth.

Shares of Anteris Technologies Global Corp. (ASX:AVR) surged 32.92% to AUD 9.69 on 21 January 2026, following the announcement of a proposed USD 200 million public offering and a strategic private placement with Medtronic. The capital raising is intended to support clinical trials, expand …